Mitotic and gender parallels in Alzheimer disease: Therapeutic opportunities

X. Zhu, K. M. Webber, G. Casadesus, A. K. Raina, H. G. Lee, M. Marlatt, A. Hartzler, C. S. Atwood, R. Bowen, G. Perry, Mark A. Smith

Research output: Contribution to journalReview articlepeer-review

8 Scopus citations


In this review, we discuss the role of cell cycle dysfunction in the pathogenesis of Alzheimer disease and propose that such mitotic catastrophe, as one of the earliest events in neuronal degeneration, may, in fact, be sufficient to initiate the neurodegenerative cascade. The question as to what molecule initiates cell cycle dysfunction is now beginning to become understood and, in this regard, the gender-predication, age-related penetrance and regional susceptibility of specific neuronal populations led us to consider luteinizing hormone as a key mediator of the abnormal mitotic process. As such, agents targeted toward luteinizing hormone or downstream sequelae may be of great therapeutic value in the treatment of Alzheimer disease.

Original languageEnglish (US)
Pages (from-to)559-563
Number of pages5
JournalCurrent drug targets
Issue number6
StatePublished - Aug 2004
Externally publishedYes


  • Alzheimer disease
  • Amyloid-β
  • Cell cycle
  • Leuprolide acetate
  • Luteinizing hormone
  • Oxidative stress
  • Tau phosphorylation

ASJC Scopus subject areas

  • Drug Discovery
  • Molecular Medicine
  • Clinical Biochemistry
  • Pharmacology


Dive into the research topics of 'Mitotic and gender parallels in Alzheimer disease: Therapeutic opportunities'. Together they form a unique fingerprint.

Cite this